Neuroprotective Effect of SGLT2 Inhibitors

Patients with diabetes are at higher risk of cardiovascular diseases and cognitive impairment. SGLT2 inhibitors (Empagliflozin, Canagliflozin, Dapagliflozin, Ertugliflozin, Sotagliflozin) are newer hypoglycemic agents with many pleiotropic effects. In this review, we discuss their neuroprotective po...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawlos, Agnieszka, Broncel, Marlena, Woźniak, Ewelina, Gorzelak-Pabiś, Paulina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659196/
https://www.ncbi.nlm.nih.gov/pubmed/34885795
http://dx.doi.org/10.3390/molecules26237213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659196/
https://www.ncbi.nlm.nih.gov/pubmed/34885795
http://dx.doi.org/10.3390/molecules26237213

Ejemplares similares